Delivery Order SPE2DB22D3401-SPE2DB25FT0QB

Award Date 11/6/24
Potential Completion Date 11/7/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,089.89, is for the delivery of 4,563,718,136 tablets of the medication mirtazapine 30 mg, with a completion date of February 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,069.92 firm fixed-price delivery order is for the supply of 4,566,675,024 units of Mirtazapine 7.5 mg tablets, a medication used to treat mental health conditions. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,413.88 firm fixed-price delivery order is for the supply of 4,567,724,925 units of the pharmaceutical drug mirtazapine 7.5 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,402.15 firm fixed-price delivery order is for the supply of 4558748574 - Mirtazapine 7.5 mg tablets in 30-count packages. The contract has an ultimate completion date of October 13, 2022 and was awarded on October 12, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,053.26 firm fixed-price delivery order is for the supply of 4,555,552,160 units of Mirtazapine 15 mg tablets. The contract has an ultimate completion date of December 1, 2021 and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,173.98 contract is for the delivery of 4,567,165 tablets of the prescription medication mirtazapine 7.5 mg. The contract is a firm fixed-price delivery order with a period of performance through February 6, 2025. This contract award is not associated with a set-aside designation. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,555.98 firm fixed-price delivery order is for the supply of Mirtazapine 7.5mg tablets, a medication used to treat mental health conditions. The award is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,144.24 Firm Fixed Price delivery order is for the supply of 4,554,483,108 units of Mirtazapine 30mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,530.65 firm-fixed-price delivery order is for the supply of Mirtazapine 7.5 mg tablets. The contract has a completion date of September 13, 2024 and was awarded on September 12, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that Amerisourcebergen holds with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to supply 1,000 units of 15 mg Mirtazapine tablets. The $1,044.90 contract has a completion date of February 22, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, holds a larger indefinite delivery contract...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB25FT0QB
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,479.36 firm fixed-price delivery order is for the supply of 4,566,358,673 tablets of the prescription medication mirtazapine 15 mg.

The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

This contract award was not designated as a set-aside, indicating open competition. The contract will be performed in Conshohocken, Pennsylvania, and has a completion date of November 7, 2024.

Generated 5/20/25, 1:53 PM